T1 Organism 1258 1269 AA-enhanced
T2 Gene 855 863  mTORC1 
T3 Protein 641 645 mTOR
T4 Protein 35 39 mTOR
T5 Condition 1311 1316 tumor
T6 Protein 4 33 mammalian target of rapamycin
T7 Protein 1360 1369 rapamycin
T8 Gene 384 453  strongly correlated with the signaling activity of mTORC1 and mTORC2
T9 Condition 574 587 breast cancer
T11 Gene 989 1010 ras homolog enriched 
T12 Biomarker 1232 1237 COX-2
T14 Gene 1012 1016  bra
T15 Protein 24 33 rapamycin
T16 Gene 625 640 mTOR complex 1 
T17 Organism 1284 1295 rat mammary
T18 Protein 919 923 mTOR
T19 Condition 1532 1545 breast cancer
T20 Intervention 254 261 mammary
T21 Organism 1243 1249 animal
T22 Condition 547 552 tumor
T23 Condition 102 109 cancers
T24 Condition 534 560 human breast tumor tissues
T25 Gene 648 659  and mTORC2
T26 Protein 1072 1074 AA
T27 Protein 1131 1135 mTOR
T28 Protein 1258 1260 AA
T29 Protein 625 629 mTOR
T30 Protein 1442 1446 mTOR
T31 Protein 676 678 AA
T32 Condition 1296 1301 tumor
T33 Gene 1456 1473 AA-activated mTOR
T35 Protein 1469 1473 mTOR
T36 Gene 740 769 phosphatidylinositol 3-kinase
T37 Gene 350 377 cytosolic phospholipase A2 
T38 Gene 918 926  mTORC1 
T39 Gene 490 524 vascular epithelial growth factor 
T40 Protein 343 345 AA
T41 Protein 1456 1458 AA
T42 Gene 962 973 mTOR-raptor
T43 Protein 242 244 AA
T44 Biomarker 771 776 PI3-K
T45 Protein 436 440 mTOR
T46 Level 565 593 cultured breast cancer cells
T47 Protein 447 451 mTOR
T48 Biomarker 727 738 amino acids
T49 Protein 129 131 AA
T50 Protein 653 657 mTOR
T51 Protein 595 597 AA
T52 Protein 1168 1170 AA
T53 Condition 194 207 breast cancer
T54 Protein 905 907 AA
T55 Gene 435 443  mTORC1 
T56 Gene 111 127 Arachidonic acid
T57 Protein 690 694 mTOR
T58 Protein 1201 1204 LOX
T59 Intervention 1416 1429 intracellular
T60 Condition 262 267 tumor
T61 Protein 962 966 mTOR
T62 Protein 1397 1399 AA
T63 Protein 812 816 TSC2
T64 Protein 1214 1230 cyclooxygenase-2
T65 Condition 1515 1520 tumor
T66 Protein 856 860 mTOR
T68 Protein 1187 1199 lipoxygenase
T69 Gene 782 810 tuberous sclerosis complex 2
